Evidence map›Paper›PMID 21422097›Full record

ArticleHuman molecular genetics2011

Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.

Celeste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, Kirsten Moysich, Chris Hsu, Kara L Cushing-Haugen, David V Conti, Susan J Ramus, Aleksandra Gentry-Maharaj, Usha Menon and 27 more

Abstract readMulticenter Study
In one paragraph

Article in Human molecular genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
    Pooled it
  2. Role ofFrontiers in genetics · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 10 institutions in 5 countries.

Celeste Leigh PearceDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA 90033, USA. cpearce@usc.edu
Jennifer A Doherty
David J Van Den Berg
Kirsten Moysich
Chris Hsu
Kara L Cushing-Haugen
David V Conti
Susan J Ramus
Aleksandra Gentry-Maharaj
Usha Menon
Simon A Gayther
Paul D P Pharoah
Honglin Song
Susanne K Kjaer
Estrid Hogdall
Claus Hogdall
Alice S Whittemore
Valerie McGuire
Weiva Sieh
Jacek Gronwald
Krzysztof Medrek
Anna Jakubowska
Jan Lubinski
Georgia Chenevix-Trench
AOCS/ACS Study Group
Jonathan Beesley
Penelope M Webb
Andrew Berchuck
Joellen M Schildkraut
Edwin S Iversen
Patricia G Moorman
Christopher K Edlund
Daniel O Stram
Malcolm C Pike
Roberta B Ness
Mary Anne Rossing
Anna H Wu
University of Southern California · USPomeranian Medical University · PLQIMR Berghofer Medical Research Institute · AUUniversity College London · GBFred Hutch Cancer Center · USStanford University · USDanish Cancer Society · DKDuke University · USUniversity of Cambridge · GBRoswell Park Comprehensive Cancer Center · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
USC CANCER EPIDEMIOLOGY &BIOSTATISTICS UNITP01CA017054 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WU, ANNA H. · 1985 to 2009
$18.2M
The Molecular Epidemiology Of Ovarian CancerR01CA076016 · NCI · DUKE UNIVERSITY · PI SCHILDKRAUT, JOELLEN M. · 1998 to 2010
$6.2M
Epidemiology of Ovarian Cancer:New HypothesesR01CA087538 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2002 to 2006
$3.5M
Steroid Hormone Genes and Ovarian Cancer RiskR01CA112523 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2006 to 2010
$3.3M
Inflammation and Ovarian CancerR01CA095023 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUNKER, CLAREANN H. · 2003 to 2008
$2.7M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067010 · PC · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROSS, RONALD K · 1996 to 2000
$2.4M
GENETIC EPIDEMIOLOGY OF OVARIAN CANCERU01CA071966 · NCI · STANFORD UNIVERSITY · PI WHITTEMORE, ALICE S · 1996 to 2002
$1.2M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSU01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 1996 to 2000
$943k
Cancer Research UK 10119Cancer Research UK 10124Cancer Research UK 11021Cancer Research UK A10119Cancer Research UK A10124Medical Research Council G0801875NCI NIH HHS CA14089NCI NIH HHS CA16056NCI NIH HHS CA17054NCI NIH HHS CA61132NCI NIH HHS CA63464NCI NIH HHS K07 CA143047NCI NIH HHS K07CA143047NCI NIH HHS N01-PC-67010NCI NIH HHS R01 CA087538NCI NIH HHS R01CA095023NCI NIH HHS R01 CA112523NCI NIH HHS R01CA112523NCI NIH HHS R01-CA61107NCI NIH HHS R01-CA76016NCI NIH HHS R01CA87538NCI NIH HHS R03-CA113148NCI NIH HHS U01 CA69417NCI NIH HHS U01 CA71966
6 · The paper itself

Abstract

The insulin-like growth factor (IGF) signaling axis plays an important role in cancer biology. We hypothesized that genetic variation in this pathway may influence risk of ovarian cancer. A three-center study of non-Hispanic whites including 1880 control women, 1135 women with invasive epithelial ovarian cancer and 321 women with borderline epithelial ovarian tumors was carried out to test the association between tag single-nucleotide polymorphisms (tSNPs) (n=58) in this pathway and risk of ovarian cancer. We found no association between variation in IGF1, IGFBP1 or IGFBP3 and risk of invasive disease, whereas five tSNPs in IGF2 were associated with risk of invasive epithelial ovarian cancer at P<0.05 and followed-up one of the associated SNPs. We conducted genotyping in 3216 additional non-Hispanic white cases and 5382 additional controls and were able to independently replicate our initial findings. In the combined set of studies, rs4320932 was associated with a 13% decreased risk of ovarian cancer per copy of the minor allele carried (95% confidence interval 0.81-0.93, P-trend=7.4 × 10(-5)). No heterogeneity of effect across study centers was observed (p(het)=0.25). IGF2 is emerging as an important gene for ovarian cancer; additional genotyping is warranted to further confirm these associations with IGF2 and to narrow down the region harboring the causal SNP.

Indexed as

Polymorphism, Single NucleotideAdultAgedCarcinoma, Ovarian EpithelialCase-Control StudiesFemaleGenetic HeterogeneityGenetic Predisposition to DiseaseGenotypeHumansInsulin-Like Growth Factor Binding Protein 1Insulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor Binding ProteinsInsulin-Like Growth Factor IInsulin-Like Growth Factor IIMiddle AgedIGFBP1 protein, humanIGFBP3 protein, humanInsulin-Like Growth Factor Binding Protein 1Insulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor Binding ProteinsInsulin-Like Growth Factor IInsulin-Like Growth Factor II

Identifiers

PMID21422097
PMCPMC3090188
OpenAlexW2167116536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.